Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1166588 NEW YORK, NY

Position in LGND

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$29,735,218
+$22,764,439 QoQ
Shares Held
94,072
+169.4% QoQ
Ownership
0.472%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#49
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Derivatives in LGND

reported options exposure · as of Jun 30, 2026
CallValue
$1,169,533
CallShares
3,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. LGND ranks #39 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,735,218 94,072
2026-06-30 $1,169,533 3,700
2026-03-31 $6,970,779 34,915
2025-12-31 $6,609,319 34,957
2025-09-30 $724,856 4,092
2025-06-30 $238,273 2,096
2025-03-31 $148,878 1,416
2024-12-31 $260,160 2,428
2024-09-30 $415,974 4,156
2024-06-30 $483,820 5,742
2024-03-31 $679,537 9,296
2023-12-31 $1,319,984 18,482
2023-09-30 $1,245,197 20,781
2023-06-30 $411,835 5,712
2023-03-31 $797,022 10,835
2022-12-31 $254,641 3,812
2022-09-30 $1,453,019 16,874
2022-06-30 $381,950 4,281
2022-03-31 $567,287 5,043
2021-12-31 $1,576,572 10,207
2021-09-30 $2,416,643 17,346
2021-06-30 $419,020 3,194
2021-03-31 $569,705 3,737
2020-12-31 $215,806 2,170
2020-09-30 $205,509 2,156
2020-06-30 $325,595 2,911
2020-03-31 $1,078,291 14,828